Aspirin and Extended - Release Dipyridamole
Aspirin and Extended - Release Dipyridamole is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg. Available dosage form: capsule.
Drug Details
- Generic Name
- Aspirin and Extended - Release Dipyridamole
- Brand Names
- Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg
- Application Number
- ANDA207944
- Sponsor
- Major Pharmaceuticals
- NDC Codes
- 2
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- ASPIRIN, DIPYRIDAMOLE
Indications and Usage
1 INDICATIONS AND USAGE Aspirin and Extended-Release Dipyridamole Capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and Extended-Release Dipyridamole Capsule is a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )